The evolution of medical imaging from qualitative to quantitative: opportunities, challenges, and approaches (Conference Presentation)

Over the past decade, there has been an increasing focus on quantitative imaging biomarkers (QIBs), which are defined as “objectively measured characteristics derived from in vivo images as indicators of normal biological processes, pathogenic processes, or response to a therapeutic intervention”1. To evolve qualitative imaging assessments to the use of QIBs requires the development and standardization of data acquisition, data analysis, and data display techniques, as well as appropriate reporting structures. As such, successful implementation of QIB applications relies heavily on expertise from the fields of medical physics, radiology, statistics, and informatics as well as collaboration from vendors of imaging acquisition, analysis, and reporting systems. When successfully implemented, QIBs will provide image-derived metrics with known bias and variance that can be validated with anatomically and physiologically relevant measures, including treatment response (and the heterogeneity of that response) and outcome. Such non-invasive quantitative measures can then be used effectively in clinical and translational research and will contribute significantly to the goals of precision medicine. This presentation will focus on 1) outlining the opportunities for QIB applications, with examples to demonstrate applications in both research and patient care, 2) discussing key challenges in the implementation of QIB applications, and 3) providing overviews of efforts to address such challenges from federal, scientific, and professional organizations, including, but not limited to, the RSNA, NCI, FDA, and NIST. 1Sullivan, Obuchowski, Kessler, et al. Radiology, epub August 2015.